LOCAL NON-PES EVENTS
CLINICAL TRIALS
The ReTRIACt Study has a clinical trial site in PA .
ReTRIACt is an open clinical trial that is evaluating a study drug to determine its safety and efficacy in boys aged four and older with Monocarboxylate Transporter 8 Deficiency (MCT8 deficiency), also known as Allan-Herndon-Dudley syndrome
Next Meeting
Wednesday
October 8, 2025
6:00 to 8:30 pm
